EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
-
Meta Analysis Comparative Study
A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis.
Percutaneous revascularisation triage has not been evaluated in randomised controlled trials of patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and multivessel disease. As a result, current guidelines are not available. The objective of our meta-analysis was to investigate the use of percutaneous coronary intervention (PCI) in culprit and non-culprit vessels. ⋯ No significant difference was demonstrated in the long-term risk of myocardial infarction and mortality between multivessel PCI and culprit vessel PCI. Therefore, multivessel PCI may be a safe and reasonable option for NSTE-ACS patients with multivessel disease.
-
Mitral regurgitation is a source of significant morbidity and mortality with growing prevalence in an increasingly ageing population. The development of reparative percutaneous techniques allows offering treatment to patients ineligible for surgery. The mitral valve is a complex structure and these procedures are limited by anatomical variability and technical complexity. The most established mitral valve repair technique currently is the MitraClip, which requires a careful preoperative evaluation of the mitral valve apparatus to assess the patient's suitability for the intervention, where echocardiography plays an essential role.
-
The surgical treatment of isolated and concomitant tricuspid valve disease, especially functional tricuspid valve regurgitation, remains controversial. Functional tricuspid regurgitation may be classified into defined stages, and surgical treatment may be tailored to the extent of the disease. This report describes current surgical techniques for tricuspid valve surgery and their results.